Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8571 |
High Similarity |
NPD3027 |
Phase 3 |
0.8496 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8433 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8421 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8382 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8382 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8258 |
Intermediate Similarity |
NPD4749 |
Approved |
0.8222 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8102 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7971 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.797 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7941 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7883 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7803 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7795 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7754 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7712 |
Intermediate Similarity |
NPD2801 |
Approved |
0.771 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7707 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7674 |
Intermediate Similarity |
NPD228 |
Approved |
0.7597 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7591 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7591 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7586 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7578 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7562 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7557 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7536 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7532 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7519 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7519 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7518 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7481 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7467 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7432 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD37 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7368 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7364 |
Intermediate Similarity |
NPD2342 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7287 |
Intermediate Similarity |
NPD968 |
Approved |
0.7278 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7278 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.726 |
Intermediate Similarity |
NPD1607 |
Approved |
0.725 |
Intermediate Similarity |
NPD6746 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD846 |
Approved |
0.7244 |
Intermediate Similarity |
NPD940 |
Approved |
0.7205 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.72 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7194 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7194 |
Intermediate Similarity |
NPD1611 |
Approved |
0.719 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7183 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7181 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7174 |
Intermediate Similarity |
NPD4626 |
Approved |
0.717 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7165 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7165 |
Intermediate Similarity |
NPD289 |
Clinical (unspecified phase) |
0.7164 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7132 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7124 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7123 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7123 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7123 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7123 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7121 |
Intermediate Similarity |
NPD5451 |
Approved |
0.712 |
Intermediate Similarity |
NPD844 |
Approved |
0.7117 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7105 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7078 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7063 |
Intermediate Similarity |
NPD288 |
Approved |
0.7059 |
Intermediate Similarity |
NPD709 |
Approved |
0.7047 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7044 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7013 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD2797 |
Approved |
0.6988 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6987 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD1651 |
Approved |
0.6972 |
Remote Similarity |
NPD6582 |
Phase 2 |
0.6972 |
Remote Similarity |
NPD6583 |
Phase 3 |
0.697 |
Remote Similarity |
NPD290 |
Approved |
0.6968 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD5735 |
Approved |
0.6957 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6953 |
Remote Similarity |
NPD3020 |
Approved |
0.695 |
Remote Similarity |
NPD3705 |
Approved |
0.6948 |
Remote Similarity |
NPD7124 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD7054 |
Approved |
0.6944 |
Remote Similarity |
NPD4624 |
Approved |
0.6939 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6936 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD5494 |
Approved |
0.6929 |
Remote Similarity |
NPD5846 |
Approved |
0.6929 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6929 |
Remote Similarity |
NPD1778 |
Approved |
0.6928 |
Remote Similarity |
NPD7466 |
Approved |
0.6928 |
Remote Similarity |
NPD3750 |
Approved |
0.6923 |
Remote Similarity |
NPD1283 |
Approved |
0.6923 |
Remote Similarity |
NPD8651 |
Approved |
0.6923 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6918 |
Remote Similarity |
NPD7095 |
Approved |
0.6917 |
Remote Similarity |
NPD2684 |
Approved |
0.6914 |
Remote Similarity |
NPD4055 |
Discovery |
0.6914 |
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD7472 |
Approved |
0.6903 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6901 |
Remote Similarity |
NPD1608 |
Approved |
0.6899 |
Remote Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.6894 |
Remote Similarity |
NPD5402 |
Approved |
0.6894 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6892 |
Remote Similarity |
NPD943 |
Approved |
0.6892 |
Remote Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6883 |
Remote Similarity |
NPD6190 |
Approved |
0.6882 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6867 |
Remote Similarity |
NPD6111 |
Discontinued |
0.6864 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6859 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6857 |
Remote Similarity |
NPD5691 |
Approved |
0.6855 |
Remote Similarity |
NPD4675 |
Approved |
0.6855 |
Remote Similarity |
NPD4678 |
Approved |
0.6852 |
Remote Similarity |
NPD6788 |
Approved |
0.685 |
Remote Similarity |
NPD2860 |
Approved |
0.685 |
Remote Similarity |
NPD2859 |
Approved |
0.6849 |
Remote Similarity |
NPD596 |
Approved |
0.6849 |
Remote Similarity |
NPD600 |
Approved |
0.6848 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6848 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6846 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6842 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD5763 |
Approved |
0.6842 |
Remote Similarity |
NPD5762 |
Approved |
0.6835 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6831 |
Remote Similarity |
NPD3092 |
Approved |
0.6824 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6824 |
Remote Similarity |
NPD2674 |
Phase 3 |
0.6818 |
Remote Similarity |
NPD7003 |
Approved |
0.6815 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6812 |
Remote Similarity |
NPD7157 |
Approved |
0.6806 |
Remote Similarity |
NPD2922 |
Phase 1 |
0.6797 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6797 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6795 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6795 |
Remote Similarity |
NPD7041 |
Phase 2 |
0.6795 |
Remote Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.6792 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD2796 |
Approved |
0.6774 |
Remote Similarity |
NPD2219 |
Phase 1 |
0.6774 |
Remote Similarity |
NPD2677 |
Approved |
0.6772 |
Remote Similarity |
NPD2933 |
Approved |
0.6772 |
Remote Similarity |
NPD2934 |
Approved |
0.6772 |
Remote Similarity |
NPD9296 |
Approved |
0.6763 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6757 |
Remote Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.6757 |
Remote Similarity |
NPD3268 |
Approved |
0.6755 |
Remote Similarity |
NPD4538 |
Approved |
0.6755 |
Remote Similarity |
NPD4536 |
Approved |
0.6755
|
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |